HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1827879Generated: October 26, 2026
2-methyl-5-[[(2S)-oxiran-2-yl]methoxy]-1,3-benzothiazole → (2R)-3-((2S)-4-{[5-(2-fluorophenyl)isoxazol-3-yl]methyl}-2-methylpiperazinyl)-1-(2-methylbenzothiazol-5-yloxy)propan-2-ol
https://huagongshe.com/reaction/1827879
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 2-methyl-5-[[(2S)-oxiran-2-yl]methoxy]-1,3-benzothiazole | HCID 23598944 | — |
| Reactant | (3S)-1-{[5-(2-Fluorophenyl)-1,2-oxazol-3-yl]methyl}-3-methylpiperazine | HCID 69600490 | — |
| Solvent | 2-Methyl-2-butanol | HCID 6405 | — |
| Product | (2R)-3-((2S)-4-{[5-(2-fluorophenyl)isoxazol-3-yl]methyl}-2-methylpiperazinyl)-1-(2-methylbenzothiazol-5-yloxy)propan-2-ol | HCID 69600543 | — |
Reaction Steps
To a solution of 3-[((3S)-3-methylpiperazinyl)methyl]-5-(2-fluorophenyl)isoxazole (28 mg, 0.10 mmol) in tert-amyl alcohol (5 mL) was added 5-[((2S)oxiran-2-yl)methoxy]-2-methylbenzothiazole (22 mg, 0.10 mmol). The reaction mixture was stirred at 95° C. for 1 day. It was then cooled, concentrated, and purified by preparative chromatography (1:19 methanol:methylene chloride) to afford (2R)-3-((2S)-4-{[5-(2-fluorophenyl)isoxazol-3-yl]methyl}-2-methylpiperazinyl)-1-(2-methylbenzothiazol-5-yloxy)propan-2-ol (M+1=497.27).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07056924B2 |
|---|
| Source dataset | uspto-grants-2006_06 |
|---|
| ORD ID | ord-fe8547d0763a4306945480f09f630413 |
|---|
| Source note | uspto-grants-2006_06 |
|---|